{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:19:38Z","timestamp":1788427178413,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Spontaneous preterm birth, defined as delivery before 37 weeks of gestation, remains a global cause of neonatal illness and death, yet treatments for preterm labor remain limited. We hypothesized that K\n                      <jats:sub>V<\/jats:sub>\n                      7 channels in the uterus (myometrium), could be a therapeutic target for preventing or treating preterm labor. The aim was to characterize K\n                      <jats:sub>V<\/jats:sub>\n                      7 channel subtypes in human myometrium present after labor onset, and to use a preterm birth mouse model to provide proof-of-principal evidence that activating these channels in vivo can delay preterm delivery.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This experimental study integrated studies of human myometrial tissue (term and preterm pregnancies,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009159 across experiments), with a RU486-induced preterm birth mouse model (C57BL\/6\u2009J,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096-9 per experimental group), and ex vivo fetal ductus arteriosus preparations (CD-1 mice,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910 per group). Molecular and protein profiling, isometric tension recordings, and functional pharmacology were used to characterize K\n                      <jats:sub>V<\/jats:sub>\n                      7 mediated regulation of human and mouse uterine contractility. In vivo dosing studies in mice assessed the effects of K\n                      <jats:sub>V<\/jats:sub>\n                      7 activators (retigabine and ML213) on delivery timing (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096-9).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We show that K\n                      <jats:sub>V<\/jats:sub>\n                      7 channels and ancillary units (KCNE1-5), are expressed in pregnant human myometrium, prior to and after the onset of labor. KCNQ4 and KCNE4 transcripts are also present in myometrium taken at preterm gestations (\u2009\u00b1\u2009labor). K\n                      <jats:sub>V<\/jats:sub>\n                      7.2-5 activators markedly reduce spontaneous contractions in human and mouse myometrium in vitro and significantly delay preterm birth in vivo with limited impact on fetal ductus arteriosus function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      These findings support K\n                      <jats:sub>V<\/jats:sub>\n                      7 activation as a promising approach to suppress uterine contractility and hence delay preterm birth, highlighting a potential new direction for either drug repurposing or therapeutic development.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s43856-026-01861-7","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:02:38Z","timestamp":1788426158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KV7 channel activation inhibits human and murine myometrium contractility and delays delivery in a mouse model of preterm birth"],"prefix":"10.1038","volume":"6","author":[{"given":"Yosef T.","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2564-7348","authenticated-orcid":false,"given":"Hiten D.","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1935-2941","authenticated-orcid":false,"given":"Evonne C.","family":"Chin-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola K.","family":"Zaleska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7920-772X","authenticated-orcid":false,"given":"Deanna C.","family":"Sekulich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Herington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip I.","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Slater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4247-0281","authenticated-orcid":false,"given":"Sarah K.","family":"England","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain A.","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4740-4307","authenticated-orcid":false,"given":"Paul D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3675-9978","authenticated-orcid":false,"given":"Rachel M.","family":"Tribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"1861_CR1","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/S2214-109X(18)30451-0","volume":"7","author":"S Chawanpaiboon","year":"2019","unstructured":"Chawanpaiboon, S. et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob. Health 7, e37\u2013e46 (2019).","journal-title":"Lancet Glob. Health"},{"key":"1861_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.siny.2015.12.011","volume":"21","author":"HA Frey","year":"2016","unstructured":"Frey, H. A. & Klebanoff, M. A. The epidemiology, etiology, and costs of preterm birth. Semin Fetal Neonatal Med. 21, 68\u201373 (2016).","journal-title":"Semin Fetal Neonatal Med."},{"key":"1861_CR3","doi-asserted-by":"publisher","first-page":"262sr265","DOI":"10.1126\/scitranslmed.3009871","volume":"6","author":"CE Rubens","year":"2014","unstructured":"Rubens, C. E. et al. Prevention of preterm birth: harnessing science to address the global epidemic. Sci. Transl. Med. 6, 262sr265 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1861_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/AOG.0000000000001923","volume":"129","author":"JN Martin Jr.","year":"2017","unstructured":"Martin, J. N. Jr., D\u2019Alton, M., Jacobsson, B. & Norman, J. E. In pursuit of progress toward effective preterm birth reduction. Obstet. Gynecol. 129, 715\u2013719 (2017).","journal-title":"Obstet. Gynecol."},{"key":"1861_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-023-05842-9","volume":"23","author":"ARA McDougall","year":"2023","unstructured":"McDougall, A. R. A. et al. New medicines for spontaneous preterm birth prevention and preterm labour management: landscape analysis of the medicine development pipeline. BMC Pregnancy Childbirth 23, 525 (2023).","journal-title":"BMC Pregnancy Childbirth"},{"key":"1861_CR6","unstructured":"NICE. Overview: Preterm labour and birth, guidance. (NICE, 2015)."},{"key":"1861_CR7","doi-asserted-by":"crossref","unstructured":"Practice bulletin No. 171 summary: management of peterm labor. Obstet Gynecol 128, 931\u2013933 (2016).","DOI":"10.1097\/AOG.0000000000001702"},{"key":"1861_CR8","doi-asserted-by":"publisher","first-page":"e6226","DOI":"10.1136\/bmj.e6226","volume":"345","author":"DM Haas","year":"2012","unstructured":"Haas, D. M., Caldwell, D. M., Kirkpatrick, P., McIntosh, J. J. & Welton, N. J. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 345, e6226 (2012).","journal-title":"BMJ"},{"key":"1861_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1146\/annurev-physiol-032420-035509","volume":"83","author":"S Wray","year":"2021","unstructured":"Wray, S. & Arrowsmith, S. Uterine excitability and ion channels and their changes with gestation and hormonal environment. Annu Rev. Physiol. 83, 331\u2013357 (2021).","journal-title":"Annu Rev. Physiol."},{"key":"1861_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1146\/annurev-pharmtox-010617-052912","volume":"58","author":"V Barrese","year":"2018","unstructured":"Barrese, V., Stott, J. B. & Greenwood, I. A. KCNQ-encoded potassium channels as therapeutic targets. Annu. Rev. Pharm. Toxicol. 58, 625\u2013648 (2018).","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"1861_CR11","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1152\/physiol.00005.2022","volume":"37","author":"GW Abbott","year":"2022","unstructured":"Abbott, G. W. Kv channel ancillary subunits: where do we go from here? Physiology 37, 0 (2022).","journal-title":"Physiology"},{"key":"1861_CR12","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1113\/expphysiol.2013.075754","volume":"99","author":"IA Greenwood","year":"2014","unstructured":"Greenwood, I. A. & Tribe, R. M. Kv7 and Kv11 channels in myometrial regulation. Exp. Physiol. 99, 503\u2013509 (2014).","journal-title":"Exp. Physiol."},{"key":"1861_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1582-4934.2010.01021.x","volume":"15","author":"LA McCallum","year":"2011","unstructured":"McCallum, L. A., Pierce, S. L., England, S. K., Greenwood, I. A. & Tribe, R. M. The contribution of Kv7 channels to pregnant mouse and human myometrial contractility. J. Cell Mol. Med. 15, 577\u2013586 (2011).","journal-title":"J. Cell Mol. Med."},{"key":"1861_CR14","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00424-008-0567-5","volume":"457","author":"LA McCallum","year":"2009","unstructured":"McCallum, L. A., Greenwood, I. A. & Tribe, R. M. Expression and function of K(v)7 channels in murine myometrium throughout oestrous cycle. Pflug. Arch. 457, 1111\u20131120 (2009).","journal-title":"Pflug. Arch."},{"key":"1861_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fcvm.2017.00075","volume":"4","author":"AL Fosmo","year":"2017","unstructured":"Fosmo, A. L. & Skraastad, O. B. The Kv7 channel and cardiovascular risk factors. Front. Cardiovasc. Med. 4, 75 (2017).","journal-title":"Front. Cardiovasc. Med."},{"key":"1861_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00018-016-2359-y","volume":"74","author":"DL Greene","year":"2017","unstructured":"Greene, D. L. & Hoshi, N. Modulation of Kv7 channels and excitability in the brain. Cell Mol. Life Sci. 74, 495\u2013508 (2017).","journal-title":"Cell Mol. Life Sci."},{"key":"1861_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1476-5381.2010.01065.x","volume":"162","author":"BK Mani","year":"2011","unstructured":"Mani, B. K. & Byron, K. L. Vascular KCNQ channels in humans: the sub-threshold brake that regulates vascular tone? Br. J. Pharm. 162, 38\u201341 (2011).","journal-title":"Br. J. Pharm."},{"key":"1861_CR18","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/j.1471-0528.2011.03064.x","volume":"118","author":"S Quenby","year":"2011","unstructured":"Quenby, S., Matthew, A., Zhang, J., Dawood, F. & Wray, S. In vitro myometrial contractility reflects indication for caesarean section. BJOG 118, 1499\u20131506 (2011).","journal-title":"BJOG"},{"key":"1861_CR19","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1095\/biolreprod55.5.992","volume":"55","author":"DJ Dudley","year":"1996","unstructured":"Dudley, D. J., Branch, D. W., Edwin, S. S. & Mitchell, M. D. Induction of preterm birth in mice by RU486. Biol. Reprod. 55, 992\u2013995 (1996).","journal-title":"Biol. Reprod."},{"key":"1861_CR20","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1095\/biolreprod63.3.748","volume":"63","author":"RM Tribe","year":"2000","unstructured":"Tribe, R. M., Moriarty, P. & Poston, L. Calcium homeostatic pathways change with gestation in human myometrium. Biol. Reprod. 63, 748\u2013755 (2000).","journal-title":"Biol. Reprod."},{"key":"1861_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1161\/HYPERTENSIONAHA.111.173740","volume":"58","author":"HD Mistry","year":"2011","unstructured":"Mistry, H. D. et al. Novel expression and regulation of voltage-dependent potassium channels in placentas from women with preeclampsia. Hypertension 58, 497\u2013504 (2011).","journal-title":"Hypertension"},{"key":"1861_CR22","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.placenta.2010.02.014","volume":"31","author":"PJ Williams","year":"2010","unstructured":"Williams, P. J., Mistry, H. D., Innes, B. A., Bulmer, J. N. & Broughton Pipkin, F. Expression of AT1R, AT2R and AT4R and their roles in extravillous trophoblast invasion in the human. Placenta 31, 448\u2013455 (2010).","journal-title":"Placenta"},{"key":"1861_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.prostaglandins.2008.11.001","volume":"88","author":"J Reese","year":"2009","unstructured":"Reese, J. et al. Regulation of the fetal mouse ductus arteriosus is dependent on interaction of nitric oxide and COX enzymes in the ductal wall. Prostaglandins Other Lipid Mediat. 88, 89\u201396 (2009).","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"1861_CR24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/s41390-019-0716-x","volume":"87","author":"SL Crockett","year":"2020","unstructured":"Crockett, S. L. et al. Role of dopamine and selective dopamine receptor agonists on mouse ductus arteriosus tone and responsiveness. Pediatr. Res. 87, 991\u2013997 (2020).","journal-title":"Pediatr. Res."},{"key":"1861_CR25","doi-asserted-by":"publisher","first-page":"H687","DOI":"10.1152\/ajpheart.00294.2023","volume":"325","author":"MT Yarboro","year":"2023","unstructured":"Yarboro, M. T. et al. A novel role for PGE(2)-EP(4) in the developmental programming of the mouse ductus arteriosus: consequences for vessel maturation and function. Am. J. Physiol. Heart Circ. Physiol. 325, H687\u2013H701 (2023).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1861_CR26","doi-asserted-by":"crossref","unstructured":"Zou, M. et al. Prdm6 drives ductus arteriosus closure by promoting ductus arteriosus smooth muscle cell identity and contractility. JCI Insight 8, e163454 (2023).","DOI":"10.1172\/jci.insight.163454"},{"key":"1861_CR27","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1124\/mol.104.007112","volume":"67","author":"A Peretz","year":"2005","unstructured":"Peretz, A. et al. Meclofenamic acid and diclofenac, novel templates of KCNQ2\/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties. Mol. Pharm. 67, 1053\u20131066 (2005).","journal-title":"Mol. Pharm."},{"key":"1861_CR28","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1096\/fj.11-187609","volume":"25","author":"TK Roepke","year":"2011","unstructured":"Roepke, T. K. et al. KCNE2 forms potassium channels with KCNA3 and KCNQ1 in the choroid plexus epithelium. FASEB J. 25, 4264\u20134273 (2011).","journal-title":"FASEB J."},{"key":"1861_CR29","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/bph.12210","volume":"169","author":"UA Anderson","year":"2013","unstructured":"Anderson, U. A. et al. Functional expression of KCNQ (Kv7) channels in guinea pig bladder smooth muscle and their contribution to spontaneous activity. Br. J. Pharm. 169, 1290\u20131304 (2013).","journal-title":"Br. J. Pharm."},{"key":"1861_CR30","doi-asserted-by":"publisher","first-page":"H1288","DOI":"10.1152\/ajpheart.00757.2014","volume":"309","author":"WJ Liu","year":"2015","unstructured":"Liu, W. J. et al. Manipulation of KCNE2 expression modulates action potential duration and Ito and IK in rat and mouse ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 309, H1288\u2013H1302 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1861_CR31","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1096\/fj.12-214056","volume":"27","author":"CC Sachse","year":"2013","unstructured":"Sachse, C. C. et al. BACE1 and presenilin\/gamma-secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage-gated potassium channels. FASEB J. 27, 2458\u20132467 (2013).","journal-title":"FASEB J."},{"key":"1861_CR32","doi-asserted-by":"publisher","first-page":"H910","DOI":"10.1152\/ajpheart.00691.2011","volume":"302","author":"M Zhang","year":"2012","unstructured":"Zhang, M. et al. KCNE2 protein is more abundant in ventricles than in atria and can accelerate hERG protein degradation in a phosphorylation-dependent manner. Am. J. Physiol. Heart Circ. Physiol. 302, H910\u2013H922 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1861_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006330","volume":"4","author":"SM Clancy","year":"2009","unstructured":"Clancy, S. M., Chen, B., Bertaso, F., Mamet, J. & Jegla, T. KCNE1 and KCNE3 beta-subunits regulate membrane surface expression of Kv12.2 K(+) channels in vitro and form a tripartite complex in vivo. PLoS One 4, e6330 (2009).","journal-title":"PLoS One"},{"key":"1861_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1113\/jphysiol.2002.017301","volume":"542","author":"M Grunnet","year":"2002","unstructured":"Grunnet, M. et al. KCNE4 is an inhibitory subunit to the KCNQ1 channel. J. Physiol. 542, 119\u2013130 (2002).","journal-title":"J. Physiol."},{"key":"1861_CR35","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.yjmcc.2004.11.012","volume":"38","author":"AL Lundquist","year":"2005","unstructured":"Lundquist, A. L. et al. Expression of multiple KCNE genes in human heart may enable variable modulation of I(Ks). J. Mol. Cell Cardiol. 38, 277\u2013287 (2005).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1861_CR36","unstructured":"Yu, H. et al. A small molecule activator of KCNQ2 and KCNQ4 channels. in Probe Reports from the NIH Molecular Libraries Program (NIH, 2010)."},{"key":"1861_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114952","volume":"164","author":"M Villegas-Esguevillas","year":"2023","unstructured":"Villegas-Esguevillas, M. et al. The novel K(V)7 channel activator URO-K10 exerts enhanced pulmonary vascular effects independent of the KCNE4 regulatory subunit. Biomed. Pharmacother. 164, 114952 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"1861_CR38","unstructured":"Grand View Research. Ion channels in drug discovery, 2023 report. (Martket Trends Reports, 2023)."},{"key":"1861_CR39","unstructured":"Rogers, M. Ion channel drug discovery and modern medicine. 9-11 (Metrion Biosciences, 2019)."},{"key":"1861_CR40","doi-asserted-by":"publisher","first-page":"999369","DOI":"10.3389\/fphys.2022.999369","volume":"13","author":"EA Pereira da Silva","year":"2022","unstructured":"Pereira da Silva, E. A., Martin-Aragon Baudel, M., Navedo, M. F. & Nieves-Cintron, M. Ion channel molecular complexes in vascular smooth muscle. Front. Physiol. 13, 999369 (2022).","journal-title":"Front. Physiol."},{"key":"1861_CR41","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3389\/fphys.2020.01004","volume":"11","author":"J Malysz","year":"2020","unstructured":"Malysz, J. & Petkov, G. V. Detrusor smooth muscle K(V)7 channels: emerging new regulators of urinary bladder function. Front. Physiol. 11, 1004 (2020).","journal-title":"Front. Physiol."},{"key":"1861_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-5-41","volume":"5","author":"RC Smith","year":"2007","unstructured":"Smith, R. C., McClure, M. C., Smith, M. A., Abel, P. W. & Bradley, M. E. The role of voltage-gated potassium channels in the regulation of mouse uterine contractility. Reprod. Biol. Endocrinol. 5, 41 (2007).","journal-title":"Reprod. Biol. Endocrinol."},{"key":"1861_CR43","unstructured":"Tribe, R.M. & Taggart, M.J. Cellular ionic mechanisms controlling uterine smooth muscle contraction: effects of gestational state. In New Frontiers in Smooth Muscle Biology and Physiology, Vol. 1 (ed. Savinneau, J.P.) 523\u2013549 (Research Signpost, 2007)."},{"key":"1861_CR44","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/biolre\/ioad174","volume":"110","author":"J Bao","year":"2024","unstructured":"Bao, J. et al. BKCa channels are involved in spontaneous and lipopolysaccharide-stimulated uterine contraction in late gestation mice. Dagger Biol. Reprod. 110, 798\u2013807 (2024).","journal-title":"Dagger Biol. Reprod."},{"key":"1861_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5108","volume":"5","author":"HC Parkington","year":"2014","unstructured":"Parkington, H. C. et al. Diminished hERG K+ channel activity facilitates strong human labour contractions but is dysregulated in obese women. Nat. Commun. 5, 4108 (2014).","journal-title":"Nat. Commun."},{"key":"1861_CR46","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1095\/biolreprod.115.129791","volume":"93","author":"CL Cowles","year":"2015","unstructured":"Cowles, C. L. et al. Alternatively spliced human TREK-1 variants alter TREK-1 channel function and localization. Biol. Reprod. 93, 122 (2015).","journal-title":"Biol. Reprod."},{"key":"1861_CR47","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1113\/JP271286","volume":"593","author":"TA Jepps","year":"2015","unstructured":"Jepps, T. A., Carr, G., Lundegaard, P. R., Olesen, S. P. & Greenwood, I. A. Fundamental role for the KCNE4 ancillary subunit in Kv7.4 regulation of arterial tone. J. Physiol. 593, 5325\u20135340 (2015).","journal-title":"J. Physiol."},{"key":"1861_CR48","doi-asserted-by":"crossref","unstructured":"Perucca, E. & Taglialatela, M. Targeting Kv7 potassium channels for epilepsy. CNS Drugs 39, 263\u2013288 (2025).","DOI":"10.1007\/s40263-024-01155-3"},{"key":"1861_CR49","first-page":"7","volume":"8","author":"K Rejdak","year":"2012","unstructured":"Rejdak, K., Luszczki, J. J., Blaszczyk, B., Chwedorowicz, R. & Czuczwar, S. J. Clinical utility of adjunctive retigabine in partial onset seizures in adults. Ther. Clin. Risk Manag 8, 7\u201314 (2012).","journal-title":"Ther. Clin. Risk Manag"},{"key":"1861_CR50","doi-asserted-by":"crossref","unstructured":"Zhang, H. et al. Neuroprotective effects, mechanisms of action and therapeutic potential of the Kv7\/KCNQ channel opener QO-83 in ischemic stroke. Transl. Stroke Res. 16, 1577\u20131593 (2025).","DOI":"10.1007\/s12975-025-01329-1"},{"key":"1861_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.101132","volume":"15","author":"B Zhang","year":"2025","unstructured":"Zhang, B. et al. Discovery of E0199: a novel compound targeting both peripheral Na(V) and K(V)7 channels to alleviate neuropathic pain. J. Pharm. Anal. 15, 101132 (2025).","journal-title":"J. Pharm. Anal."},{"key":"1861_CR52","doi-asserted-by":"publisher","first-page":"750583","DOI":"10.3389\/fpain.2021.750583","volume":"2","author":"SRA Alles","year":"2021","unstructured":"Alles, S. R. A. & Smith, P. A. Peripheral voltage-gated cation channels in neuropathic pain and their potential as therapeutic targets. Front Pain. Res (Lausanne) 2, 750583 (2021).","journal-title":"Front Pain. Res (Lausanne)"},{"key":"1861_CR53","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3389\/fphys.2020.00634","volume":"11","author":"G Mondejar-Parreno","year":"2020","unstructured":"Mondejar-Parreno, G., Perez-Vizcaino, F. & Cogolludo, A. Kv7 channels in lung diseases. Front Physiol. 11, 634 (2020).","journal-title":"Front Physiol."},{"key":"1861_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1476-5381.2012.02133.x","volume":"168","author":"TA Jepps","year":"2013","unstructured":"Jepps, T. A., Olesen, S. P. & Greenwood, I. A. One man\u2019s side effect is another man\u2019s therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders. Br. J. Pharm. 168, 19\u201327 (2013).","journal-title":"Br. J. Pharm."},{"key":"1861_CR55","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1113\/expphysiol.2013.072868","volume":"99","author":"YW Chan","year":"2014","unstructured":"Chan, Y. W., van den Berg, H. A., Moore, J. D., Quenby, S. & Blanks, A. M. Assessment of myometrial transcriptome changes associated with spontaneous human labour by high-throughput RNA-seq. Exp. Physiol. 99, 510\u2013524 (2014).","journal-title":"Exp. Physiol."},{"key":"1861_CR56","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1113\/jphysiol.1965.sp007591","volume":"177","author":"R Casteels","year":"1965","unstructured":"Casteels, R. & Kuriyama, H. Membrane potential and ionic content in pregnant and non-pregnant rat myometrium. J. Physiol. 177, 263\u2013287 (1965).","journal-title":"J. Physiol."},{"key":"1861_CR57","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0002-9378(99)70390-X","volume":"181","author":"HC Parkington","year":"1999","unstructured":"Parkington, H. C., Tonta, M. A., Brennecke, S. P. & Coleman, H. A. Contractile activity, membrane potential, and cytoplasmic calcium in human uterine smooth muscle in the third trimester of pregnancy and during labor. Am. J. Obstet. Gynecol. 181, 1445\u20131451 (1999).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1861_CR58","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1113\/jphysiol.2009.171272","volume":"587","author":"IA Greenwood","year":"2009","unstructured":"Greenwood, I. A., Yeung, S. Y., Tribe, R. M. & Ohya, S. Loss of functional K+ channels encoded by ether-a-go-go-related genes in mouse myometrium prior to labour onset. J. Physiol. 587, 2313\u20132326 (2009).","journal-title":"J. Physiol."},{"key":"1861_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114034","volume":"9","author":"WC Tong","year":"2014","unstructured":"Tong, W. C., Tribe, R. M., Smith, R. & Taggart, M. J. Computational modeling reveals key contributions of KCNQ and hERG currents to the malleability of uterine action potentials underpinning labor. PLoS One 9, e114034 (2014).","journal-title":"PLoS One"},{"key":"1861_CR60","doi-asserted-by":"publisher","first-page":"679317","DOI":"10.3389\/fphys.2021.679317","volume":"12","author":"TA Jepps","year":"2021","unstructured":"Jepps, T. A., Barrese, V. & Miceli, F. Editorial: Kv7 channels: structure, physiology, and pharmacology. Front. Physiol. 12, 679317 (2021).","journal-title":"Front. Physiol."},{"key":"1861_CR61","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1097\/01.ogx.0001172284.90993.46","volume":"80","author":"N Melamed","year":"2025","unstructured":"Melamed, N. et al. Timing of antenatal corticosteroid administration and neonatal outcomes. Obstet. Gynecol. Surv. 80, 685\u2013687 (2025).","journal-title":"Obstet. Gynecol. Surv."},{"key":"1861_CR62","volume":"8","author":"A Wilson","year":"2022","unstructured":"Wilson, A. et al. Tocolytics for delaying preterm birth: a network meta-analysis (0924). Cochrane Database Syst. Rev. 8, CD014978 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1861_CR63","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1161\/ATVBAHA.114.303405","volume":"34","author":"PS Chadha","year":"2014","unstructured":"Chadha, P. S. et al. Contribution of kv7.4\/kv7.5 heteromers to intrinsic and calcitonin gene-related peptide-induced cerebral reactivity. Arterioscler Thromb. Vasc. Biol. 34, 887\u2013893 (2014).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"1861_CR64","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1124\/mol.115.101758","volume":"89","author":"BK Mani","year":"2016","unstructured":"Mani, B. K. et al. Kv7.5 potassium channel subunits are the primary targets for PKA-dependent enhancement of vascular smooth muscle Kv7 currents. Mol. Pharm. 89, 323\u2013334 (2016).","journal-title":"Mol. Pharm."},{"key":"1861_CR65","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1212\/CON.0000000000000715","volume":"25","author":"BW Abou-Khalil","year":"2019","unstructured":"Abou-Khalil, B. W. Update on antiepileptic drugs 2019. Continuum 25, 508\u2013536 (2019).","journal-title":"Continuum"},{"key":"1861_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1021\/acsmedchemlett.8b00315","volume":"10","author":"L Wang","year":"2019","unstructured":"Wang, L., Qiao, G. H., Hu, H. N., Gao, Z. B. & Nan, F. J. Discovery of novel retigabine derivatives as potent KCNQ4 and KCNQ5 channel agonists with improved specificity. ACS Med. Chem. Lett. 10, 27\u201333 (2019).","journal-title":"ACS Med. Chem. Lett."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01861-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01861-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01861-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:02:40Z","timestamp":1788426160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01861-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1861"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01861-7","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare that they have no competing interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"447"}}